Acute Vaginal Candidiasis: Another Step Forward to the Deeper Understanding
Article Sidebar
Main Article Content
Abstract
trinsic factors, including diet, hormonal fluctuations, and genital hygiene. The predominant causative organisms are Candida spp., with C. albicans being the most prevalent. Candida spp. are part of the normal flora residing on the vaginal mucosa and other mucous membranes throughout the body. The human body employs numerous mechanisms to maintain equilibrium between these fungi and commensal bacteria. Any disruption of this equilibrium can result in Candida overgrowth, manifesting as symptoms such as profuse vaginal discharge or burning and itching of the vulvar and vaginal region. In 2022, the Royal Thai College of Obstetricians and Gynaecologists issued treatment guidelines for reproductive-age women presenting with abnormal vaginal discharge. These guidelines recommend various pharmacological regimens and behavior modifications to minimize future recurrence. Nevertheless, experts in real-world practice often suggest adaptations to these regimens to enhance therapeutic outcomes. The Siriraj Female Sexually Transmitted Infections Clinic regularly manages VC cases and implements a 2-week follow-up protocol for all patients. Given that VC is the most common diagnosis for abnormal vaginal discharge at the clinic, significant expertise has been accumulated in treating the condition. The collected perceived insights can be invaluable for fellow professionals, potentially broadening service perspectives and catalyzing further research.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Chayachinda C, Chinhiran K, Kittiyaowamarn R, Chaithongwongwatthana S, Teeratakulpisarn N. The Thai 2022 Sexually Transmitted Infections Treatment Guideline: Abnormal Vaginal Discharge. Thai J Obstet Gynaecol 2022;30:222-33.
Chayachinda C, Thamkhantho M, Chalermchockcharoenkit A, Neungton C, Thipmontree W. Characteristics of Clients at the Siriraj Female STD Clinic during 2011-2015. Siriraj Med Bull 2018;11:182-9.
Chayachinda C, Thamkhantho M, Ngamsakulringroj P, Leeyaphan C, Tulyaprawat O. Effect of intravaginal gentian violet for acute vaginal candidiasis treated with a single dose oral fluconazole: a randomised controlled trial. J Obstet Gynaecol 2022;7:1-7.
Roberts C, Algert C, Rickard K, Morris J. Treatment of vaginal candidiasis for the prevention of preterm birth: a systematic review and meta-analysis. Syst Rev 2015;4:31.
Blomberg L, Backman K, Kirjavainen P, Karvonen A, Harju M, Keski-Nisula L. Vulvovaginal yeast infections, gestational diabetes and pregnancy outcome. BMC Pregnancy Childbirth 2023;23:70.
Sobel JD. Vulvovaginal candidosis. Lancet 2007;369:1961-71.
Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 2004;329:371.
Roberts C, Rickard K, Kotsiou G, Morris J. Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial. BMC Pregnancy Childbirth 2011;11:18.
British Association for Sexual Health and HIV. British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019)2019 28 July 2020. Available from: https://www.bashhguidelines.org/media/1223/vvc-2019.pdf.
Chalermchockcharoenkit A. (24 August 2022) A novel topical alternative treatment for treating women with acute vaginal candidiasis: Sertaconazole 300 mg [Webinar]. Pacific Health Care, Thailand.
Garcia-Rubio R, de Oliveira HC, Rivera J, Trevijano-Contador N. The fungal cell wall: Candida, Cryptococcus, and Aspergillus Species. Front Microbiol 2020;10:1-13.
Lv Q, Yan L, Jiang Y. The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn. Virulence 2016;7:649-59.
d’Enfert C, Kaune A, Alaban L, Chakraborty S, Cole N, Delavy M, et al. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev 2021;45:fuaa060.
Amabebe E, Anumba DOC. The Vaginal Microenvironment: The physiologic role of Lactobacilli. Front Med (Lausanne) 2018;5:181.
King R, Lee J, Morris A. Adherence of Candida albicans and other Candida species to mucosal epithelial cells. Infect Immun 1980;27:667-74.
Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynaecol Obstet 2000;71:S21-7.
Narayanan T, Rao G. Beta-indoleethanol and beta-indolelactic acid production by Candida species: their antibacterial and autoantibiotic action. Antimicrob Agents Chemother 1976;9:375-80.
Heng L, Yatsuya H, Morita S, Sakamoto J. Vaginal douching in Cambodian women: its prevalence and association with vaginal candidiasis. J Epidemiol 2010;20:70-6.
Shaaban O, Abbas A, Moharram A, Farhan M, Hassanen I. Does vaginal douching affect the type of candidal vulvovaginal infection? Med Mycol 2015;53:817-27.
Rachapromma P, Chayachinda C, Kerdklinhom C, Iamvijarn W, Thanasakthitiku T. Nursing Care for Women with Acute Vaginal Candidiasis. Siriraj Med Bull 2022;15: 107-13.
Elegbe I, Elegbe I. Quantitative relationships of Candida albicans infections and dressing patterns in Nigerian women. Am J Public Health. 1983;73:450-2.
Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol 2003;24:444-8.
Chayachinda C, Rekhawasin T, Thamkhantho M, Aneklap P. Acute vaginal candidiasis: A review of treatment guidelines and Siriraj experience. Thai J Obstet Gynaecol 2021;29:306-12.
Royal Thai College of Obstetrics and Gynaecologists. Management of abnormal vaginal discharge in reproductive-aged women. Siriraj Med Bull 2023;16:187-29.
Tuangrattanasirikun D, Chayachinda C, Rachapromma P, Sonwicha S. Effect of on-line vs on-site class on medical students’ competency in vaginal wet mount. Siriraj Med Bull 2023;16:269-75.
Woelber L, Prieske K, Mendling W, Schmalfeldt B, Tietz H, Jaeger A. Vulvar pruritus-causes, diagnosis and therapeutic approach. Dtsch Arztebl Int 2020;116:126-33.
Chayachinda C, Panchalee T, Thamkhantho M. A Never-ending story of anogenital warts: review article. J Med Assoc Thai 2020;103:614-9.
Qi W, Li H, Wang C, Li H, Zhang B, Dong M, et al. Recent advances in presentation, diagnosis and treatment for mixed vaginitis. Front Cell Infect Microbiol 2021;11:759795.
Olson M, Jayaraman A, Kao K. Relative Abundances of Candida albicans and Candida glabrata in In Vitro Coculture Biofilms Impact Biofilm Structure and Formation. Appl Environ Microbiol 2018;84:e02769-17.
Workowski K, Bachmann L, Chan P, Johnston C, Muzny C, Park I, et al. Sexually Transmitted infections treatment guidelines 2021. MMWR Recomm Rep 2021;70:1-187.
Budani M, Fensore S, Di Marzio M, Tiboni G. Maternal use of fluconazole and congenital malformations in the progeny: A meta-analysis of the literature. Reprod Toxicol 2021;100:42-51.
Ghannoum M, Rice L. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999;12:501-17.
Regidor P, Thamkhantho M, Chayachinda C, Palacios S. Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature. J Obstet Gynaecol 2023;43:2195001.
Fan S, Liu X, Wu C, Xu L, Li J. Vaginal Nystatin Versus Oral Fluconazole for the Treatment for Recurrent Vulvovaginal Candidiasis. Mycopathologia 2015;179:95-101.
Merianoss J. Quaternary ammonium antimicrobial compounds. In: Block S, editor. Disinfection, sterilization, and preservation. Fourth ed. Philadelphia: Lea and Febiger; 1991. p. 225-55.
Thamkhantho M, Chayachinda C. Vaginal tablets of dequalinium chloride 10 mg versus clotrimazole 100 mg for vaginal candidiasis: a double-blind, randomized study. Arch Gynecol Obstet 2021;303:151-60.
Chayachinda C, Chinhiran K, Aneklap P, Rachapromma P, Sornwicha S. Bacterial Vaginosis: a comprehensive approach to management in reproductive-aged women. Thai J Obstet Gynaecol 2023;31:318-25
Hosiriphon K, Chayachinda C, Keawpoonsub K, Taibowornpitak K, Tuangrattanasirikun D. A Survey of daily genital care practices among reproductive-aged female personnel at Siriraj Hospital Siriraj Med J 2023;75:259-65
Quereux C, Gelas B, Chevallier T, Petit F, Micheletti M. Evaluation of the efficacity and speed of action of sertaconazole nitrate suppository and cream combined treatment for vulvovaginal candidiasis. Gynecol Obstet Fertil 2000;28:238-44.
Mendling W, Atef El Shazly M, Zhang L. Clotrimazole for vulvovaginal candidiasis: more than 45 years of clinical experience. Pharmaceuticals 2020;13:274.
Egorova AT, Bazina MI, Savitskaya EA. The experience of treatment of Candida vulvovaginitis in pregnant women with ‘Zalain’. Russian Bulletin of Obstetrician-Gynaecologist 2010;4:35-8